A Retrospective Review of Malignant Liver Tumors

Key facts

Sponsor

University of Oklahoma

Principal Investigator

Thomas A Broughan, MD

University of Oklahoma-Tulsa

Enrollment

228 enrolled

Eligibility

20-90 years · All sexes

Timeline

2003 – 2011

Study locations (1)

• The University of Oklahoma College of Medicine, Tulsa - Department of Surgery, Tulsa, Oklahoma, United States

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Rare tumor of liver and intrahepatic biliary tract

Additional recruiting or active studies for the same condition.

• RECRUITINGNANCT07356531
  Clinical Trial Evaluating the Safety and Efficacy of Tumor Thermosensitive Embolic Agent in Transcatheter Arterial Chemoembolization for Primary Liver Cancer
  JIANGSU SHENMING Medical Technology CO., Ltd
• ACTIVE NOT RECRUITINGNCT04145141
  National Translational Science Network of Precision-based Immunotherapy for Primary Liver Cancer
  National Cancer Institute (NCI)
• ACTIVE NOT RECRUITINGNANCT02984566
  Liver Ablative Radiotherapy Utilising Kilovoltage Intrafraction Monitoring (KIM)
  University of Sydney

See all trials for Rare tumor of liver and intrahepatic biliary tract →